SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Golden satellite insulation sparkles during test | Space photo of the day for Dec. 30, 2025 - 2Osteoporosis, the silent disease, can shorten your life − here’s how to prevent fractures and keep bones healthy
- 3Teen drug use remains low, but survey finds small rise in heroin and cocaine use
- 4SpaceX rocket launches 140 satellites into orbit on Transporter-15, aces landing at sea (video)
- 5Rachael Ray is navigating grief this holiday season. She doesn't have time for 'negative energy' on the internet.
- What causes RFK Jr.’s strained and shaky voice? A neurologist explains this little-known disorder
- Vote In favor of Your Favored Web based Dating Application
- The most effective method to Decisively Plan Your Nursing Profession for the Best Compensation Results
- The Fragrant Small Tree Birds & Pollinators Love With Stunning Flowers In Summer
- Oil Tanker Carrying Iraqi Cargo Seen Transiting Strait of Hormuz
- Six Flags Opens the Tallest, Fastest and Longest Roller Coaster in the World
- BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
- Former Australian soldier arrested over alleged Afghan war crimes
- 'Stranger Things' star debunks claims of 'unseen footage' from Season 5, Volume 2 as backlash intensifies ahead of the series finale
